BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20803015)

  • 1. p53-Dependent anticancer effects of leptomycin B on lung adenocarcinoma.
    Shao C; Lu C; Chen L; Koty PP; Cobos E; Gao W
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1369-80. PubMed ID: 20803015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line.
    Lecane PS; Kiviharju TM; Sellers RG; Peehl DM
    Prostate; 2003 Mar; 54(4):258-67. PubMed ID: 12539224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicin.
    Lu C; Shao C; Cobos E; Singh KP; Gao W
    PLoS One; 2012; 7(3):e32895. PubMed ID: 22412944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B.
    Smart P; Lane EB; Lane DP; Midgley C; Vojtesek B; Laín S
    Oncogene; 1999 Dec; 18(51):7378-86. PubMed ID: 10602494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy.
    Gao W; Lu C; Chen L; Keohavong P
    J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of p53 gene therapy and leptomycin B in human esophageal squamous cell carcinoma.
    Hoshino I; Matsubara H; Komatsu A; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Miyazawa Y; Brooks R; Yoshida M; Ochiai T
    Oncology; 2008; 75(1-2):113-9. PubMed ID: 18784437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells.
    Cromie MM; Gao W
    Oxid Med Cell Longev; 2015; 2015():217304. PubMed ID: 25922640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells.
    Liao WT; Lin P; Cheng TS; Yu HS; Chang LW
    Toxicol Appl Pharmacol; 2007 Dec; 225(2):162-70. PubMed ID: 17945324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomycin B-induced apoptosis is mediated through caspase activation and down-regulation of Mcl-1 and XIAP expression, but not through the generation of ROS in U937 leukemia cells.
    Jang BC; Paik JH; Jeong HY; Oh HJ; Park JW; Kwon TK; Song DK; Park JG; Kim SP; Bae JH; Mun KC; Suh MH; Yoshida M; Suh SI
    Biochem Pharmacol; 2004 Jul; 68(2):263-74. PubMed ID: 15193998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
    Yonesaka K; Tamura K; Kurata T; Satoh T; Ikeda M; Fukuoka M; Nakagawa K
    Int J Cancer; 2006 Feb; 118(4):812-20. PubMed ID: 16108013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.
    Chang GC; Yu CT; Tsai CH; Tsai JR; Chen JC; Wu CC; Wu WJ; Hsu SL
    Eur J Pharmacol; 2008 Dec; 600(1-3):37-44. PubMed ID: 18973751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exogenous p51a gene on the growth and chemo sensitivity of human lung adenocarcinoma cell lines.
    Shen Q; Wang H; Zhang L
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S383-S388. PubMed ID: 30095026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
    Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.